Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CEPINASDAQ:GNOMNASDAQ:SETMNASDAQ:TEKY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCEPIREX Crypto Equity Premium Income ETF$39.10+0.7%$37.22$31.35▼$52.16$40.66MN/A23,691 shs15,169 shsGNOMGlobal X Genomics & Biotechnology ETF$8.17+1.4%$7.75$6.80▼$11.88$49.51M1.0371,669 shs9,960 shsSETMSprott Critical Materials ETF$15.83+3.3%$14.10$11.48▼$19.29$39.73M1.8117,414 shs16,975 shsTEKYLazard Next Gen Technologies ETF$32.45+0.7%$29.35$24.68▼$32.56$38.94MN/A1,563 shs783 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCEPIREX Crypto Equity Premium Income ETF+2.27%-2.24%+3.44%-7.06%+3,880,999,900.00%GNOMGlobal X Genomics & Biotechnology ETF+1.77%+3.87%-1.71%-11.53%-21.67%SETMSprott Critical Materials ETF+2.03%+0.72%+6.90%+2.40%-20.41%TEKYLazard Next Gen Technologies ETF+0.88%+0.47%+8.05%+3,221,999,900.00%+3,221,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCEPIREX Crypto Equity Premium Income ETFN/AN/AN/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/ASETMSprott Critical Materials ETFN/AN/AN/AN/AN/AN/AN/AN/ATEKYLazard Next Gen Technologies ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCEPIREX Crypto Equity Premium Income ETF 2.78Moderate Buy$39.00-0.26% DownsideGNOMGlobal X Genomics & Biotechnology ETF 2.69Moderate Buy$8.17N/ASETMSprott Critical Materials ETF 2.75Moderate Buy$15.83N/ATEKYLazard Next Gen Technologies ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCEPIREX Crypto Equity Premium Income ETFN/AN/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/AN/AN/AN/AN/AN/ASETMSprott Critical Materials ETFN/AN/AN/AN/AN/AN/ATEKYLazard Next Gen Technologies ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCEPIREX Crypto Equity Premium Income ETFN/AN/A32.20∞N/AN/AN/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A-$2.34N/A∞N/AN/AN/AN/AN/ASETMSprott Critical Materials ETFN/AN/A25.12∞N/AN/AN/AN/AN/ATEKYLazard Next Gen Technologies ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCEPIREX Crypto Equity Premium Income ETF$7.4519.05%N/AN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A0.00%N/AN/AN/ASETMSprott Critical Materials ETF$0.311.96%N/AN/AN/ATEKYLazard Next Gen Technologies ETFN/AN/AN/AN/AN/ALatest SETM, CEPI, TEKY, and GNOM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/28/2025CEPIREX Crypto Equity Premium Income ETFMonthly$1.388144.09%5/29/20255/29/20255/30/20254/28/2025CEPIREX Crypto Equity Premium Income ETFMonthly$1.328643.23%4/29/20254/29/20254/30/20253/24/2025CEPIREX Crypto Equity Premium Income ETFMonthly$1.459243.63%3/25/20253/25/20253/26/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCEPIREX Crypto Equity Premium Income ETFN/AGNOMGlobal X Genomics & Biotechnology ETF56.95%SETMSprott Critical Materials ETFN/ATEKYLazard Next Gen Technologies ETFN/AInsider OwnershipCompanyInsider OwnershipCEPIREX Crypto Equity Premium Income ETFN/AGNOMGlobal X Genomics & Biotechnology ETF5.89%SETMSprott Critical Materials ETFN/ATEKYLazard Next Gen Technologies ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCEPIREX Crypto Equity Premium Income ETFN/A1.04 millionN/AN/AGNOMGlobal X Genomics & Biotechnology ETFN/A6.06 millionN/AOptionableSETMSprott Critical Materials ETFN/A2.51 millionN/ANot OptionableTEKYLazard Next Gen Technologies ETFN/A1.20 millionN/AN/ASETM, CEPI, TEKY, and GNOM HeadlinesRecent News About These CompaniesLazard Converts Mutual Fund to International Equity ETFMay 12, 2025 | etftrends.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSETM, CEPI, TEKY, and GNOM Company DescriptionsREX Crypto Equity Premium Income ETF NASDAQ:CEPI$39.10 +0.29 (+0.75%) As of 12:58 PM EasternThe REX Crypto Equity Premium Income ETF (CEPI) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is actively managed, investing in crypto-related and digital payment solutions stocks selected from the index. The fund seeks to generate income by writing covered call options on its holdings, aiming for capital growth and current income, while maintaining the flexibility to adapt based on market conditions. CEPI was launched on Dec 4, 2024 and is issued by REX Shares.Global X Genomics & Biotechnology ETF NASDAQ:GNOM$8.17 +0.11 (+1.36%) As of 01:17 PM EasternComplete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.Sprott Critical Materials ETF NASDAQ:SETM$15.83 +0.50 (+3.26%) As of 01:16 PM EasternThe Sprott Energy Transition Materials ETF (SETM) is an exchange-traded fund that mostly invests in materials equity. The fund supports the global move to cleaner energy by tracking an index of US and foreign companies related to energy transition materials. Securities are selected based on revenue and weighted by market-cap. SETM was launched on Feb 1, 2023 and is managed by Sprott.Lazard Next Gen Technologies ETF NASDAQ:TEKY$32.45 +0.23 (+0.71%) As of 01:10 PM EasternThe Lazard Next Gen Technologies ETF (TEKY) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund seeks long-term capital appreciation by actively managing a narrow portfolio of global companies involved in the developing or enabling of AI next-generation technologies. TEKY was launched on Apr 4, 2025 and is issued by Lazard. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Guidewire Rockets Higher: A Move Above $300 Is Probable TSMC Joins NVIDIA in UAE Push, Fueling Growth Outlook Constellation Energy and Meta Strike Nuclear Deal, Shares Whipsaw Archer's Midnight Air Taxi Soars, But Stock Doesn’t Budge Analog Devices' Cyclical Recovery Story Has Just Begun Microsoft Stock Near Peak, Pullback Seen as Opportunity 3 Reasons Amazon Could Be the Best Tech Performer in June 3 Tech Stocks Insiders Are Buying: Speculative Plays for June Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
